The Clinical and Economic Burden of Norovirus Gastroenteritis in the United States.

ABSTRACT:

Background

Although norovirus outbreaks periodically make headlines, it is unclear how much attention norovirus may receive otherwise. A better understanding of the burden could help determine how to prioritize norovirus prevention and control.

Methods

We developed a computational simulation model to quantify the clinical and economic burden of norovirus in the United States.

Results

A symptomatic case generated $48 in direct medical costs, $416 in productivity losses ($464 total). The median yearly cost of outbreaks was $7.6 million (range across years, $7.5-$8.2 million) in direct medical costs, and $165.3 million ($161.1-$176.4 million) in productivity losses ($173.5 million total). Sporadic illnesses in the community (incidence, 10-150/1000 population) resulted in

SUBMITTER: Bartsch SM 

PROVIDER: S-EPMC8171800 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature